DLG5 variants in inflammatory bowel disease

Carsten Büning, Lars Geerdts, Thomas Fiedler, Enno Gentz, Ghyslaine Pitre, Wolf Reuter, Werner Luck, Sabine Buhner, Tomas Molnar, Ferenc Nagy, Janos Lonovics, Axel Dignass, Olfert Landt, Renate Nickel, Janine Genschel, Herbert Lochs, Hartmut H.J. Schmidt, Heiko Witt

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

OBJECTIVES: Genetic variants within DLG5 were recently reported to be associated with inflammatory bowel disease (IBD). The aim of our study was to test for allelic and haplotype associations of six DLG5 variants in 668 IBD patients from two European populations. Furthermore, we evaluated whether DLG5 variants alter gastrointestinal permeability in Crohn's disease (CD). METHODS: Six DLG5 variants (p.R30Q, p.P1371Q, p.G1066G, rs2289308, DLG_e26, p.D1507D) were genotyped in two study populations: (1) German IBD patients (CD n = 250; ulcerative colitis (UC) n = 150) and German healthy controls (n = 422); (2) Hungarian IBD patients (CD n = 144; UC n = 124) and Hungarian healthy controls (n = 205). Subtyping analysis was performed in respect of CARD15 mutations and clinical characteristics. We also tested for differences within DLG5 genotypes in German CD patients with respect to gastroduodenal and intestinal permeability measured by triple-sugar-test. RESULTS: Allele as well as genotype frequencies of DLG5 variants did not differ between IBD patients and controls in either study population. Indeed, the p.R30Q polymorphism was found more frequently in controls than in patients. The distribution of DLG5 genotypes in German and Hungarian CD patients with CARD15 mutations was not different from patients without mutated CARD15. We did also not observe any association between DLG5 variants and clinical parameters. Importantly, DLG5 variants were not associated with gastroduodenal or intestinal permeability. CONCLUSIONS: We could not replicate that DLG5 is a relevant disease susceptibility gene for IBD in German or Hungarian subjects. In addition, we have no evidence that DLG5 variants are involved in altered gastrointestinal permeability in CD.

Original languageEnglish
Pages (from-to)786-792
Number of pages7
JournalAmerican Journal of Gastroenterology
Volume101
Issue number4
DOIs
Publication statusPublished - Apr 1 2006

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'DLG5 variants in inflammatory bowel disease'. Together they form a unique fingerprint.

  • Cite this

    Büning, C., Geerdts, L., Fiedler, T., Gentz, E., Pitre, G., Reuter, W., Luck, W., Buhner, S., Molnar, T., Nagy, F., Lonovics, J., Dignass, A., Landt, O., Nickel, R., Genschel, J., Lochs, H., Schmidt, H. H. J., & Witt, H. (2006). DLG5 variants in inflammatory bowel disease. American Journal of Gastroenterology, 101(4), 786-792. https://doi.org/10.1111/j.1572-0241.2006.00431.x